TNSN97032A1 - Nouvelles oxazolidinones substituees, procedes pour les preparer, et leur utilisation en tant que medicaments. - Google Patents

Nouvelles oxazolidinones substituees, procedes pour les preparer, et leur utilisation en tant que medicaments.

Info

Publication number
TNSN97032A1
TNSN97032A1 TNTNSN97032A TNSN97032A TNSN97032A1 TN SN97032 A1 TNSN97032 A1 TN SN97032A1 TN TNSN97032 A TNTNSN97032 A TN TNSN97032A TN SN97032 A TNSN97032 A TN SN97032A TN SN97032 A1 TNSN97032 A1 TN SN97032A1
Authority
TN
Tunisia
Prior art keywords
methods
medicaments
preparing
substituted oxazolidinones
novel substituted
Prior art date
Application number
TNTNSN97032A
Other languages
English (en)
Inventor
Bernd Riedl Dr
Dieter Habich Dr
Andreas Stolle Dr
Martin Ruppelt Dr
Stephan Bartel Dr
Walter Guarnieri Dr
Rainer Endermann Dr
Hein Peter Kroll Dr
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of TNSN97032A1 publication Critical patent/TNSN97032A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A61K31/421—1,3-Oxazoles, e.g. pemoline, trimethadione
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6564—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms
    • C07F9/6581—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and nitrogen atoms with or without oxygen or sulfur atoms, as ring hetero atoms
    • C07F9/6584—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and nitrogen atoms with or without oxygen or sulfur atoms, as ring hetero atoms having one phosphorus atom as ring hetero atom
    • C07F9/65842—Cyclic amide derivatives of acids of phosphorus, in which one nitrogen atom belongs to the ring
    • C07F9/65844—Cyclic amide derivatives of acids of phosphorus, in which one nitrogen atom belongs to the ring the phosphorus atom being part of a five-membered ring which may be condensed with another ring system

Abstract

LA PRESENTE INVENTION CONCERNE DE NOUVELLES OXAZOLIDINONES SUBSTITUES DE FORMULE GENERALE (I) OU LES SUBSTITUANTS ONT LES SIGNIFICATIONS DONNEES DANS LA DESCRIPTION, DES PROCEDES POUR LEUR PREPARTION ET LEUR UTILISATION COMME MEDICAMENTS, EN PARTICULIER COMME MEDICAMENTS ANTIIBACTERIENS.
TNTNSN97032A 1996-02-06 1997-02-04 Nouvelles oxazolidinones substituees, procedes pour les preparer, et leur utilisation en tant que medicaments. TNSN97032A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19604223A DE19604223A1 (de) 1996-02-06 1996-02-06 Neue substituierte Oxazolidinone

Publications (1)

Publication Number Publication Date
TNSN97032A1 true TNSN97032A1 (fr) 2005-03-15

Family

ID=7784633

Family Applications (1)

Application Number Title Priority Date Filing Date
TNTNSN97032A TNSN97032A1 (fr) 1996-02-06 1997-02-04 Nouvelles oxazolidinones substituees, procedes pour les preparer, et leur utilisation en tant que medicaments.

Country Status (36)

Country Link
US (1) US5792765A (fr)
EP (1) EP0789025B1 (fr)
JP (1) JPH09316073A (fr)
KR (1) KR970061888A (fr)
CN (1) CN1160051A (fr)
AR (1) AR005703A1 (fr)
AT (1) ATE200285T1 (fr)
AU (1) AU1251697A (fr)
BG (1) BG101193A (fr)
BR (1) BR9700885A (fr)
CA (1) CA2196862A1 (fr)
CO (1) CO4560411A1 (fr)
CZ (1) CZ34097A3 (fr)
DE (2) DE19604223A1 (fr)
DK (1) DK0789025T3 (fr)
EE (1) EE9700043A (fr)
ES (1) ES2157027T3 (fr)
GR (1) GR3036015T3 (fr)
HR (1) HRP970048A2 (fr)
HU (1) HUP9700358A3 (fr)
ID (1) ID15881A (fr)
IL (1) IL120125A0 (fr)
MX (1) MX9700886A (fr)
NO (1) NO970511L (fr)
NZ (1) NZ314179A (fr)
PL (1) PL318277A1 (fr)
PT (1) PT789025E (fr)
SG (1) SG50791A1 (fr)
SI (1) SI0789025T1 (fr)
SK (1) SK15897A3 (fr)
SV (1) SV1997000009A (fr)
TN (1) TNSN97032A1 (fr)
TR (1) TR199700092A2 (fr)
TW (1) TW350845B (fr)
YU (1) YU4397A (fr)
ZA (1) ZA97927B (fr)

Families Citing this family (67)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9601666D0 (en) * 1996-01-27 1996-03-27 Zeneca Ltd Chemical compounds
WO1998054161A1 (fr) * 1997-05-30 1998-12-03 Pharmacia & Upjohn Company Agents antibacteriens oxazolidinone ayant une fonctionnalite thiocarbonyle
US6255304B1 (en) 1997-05-30 2001-07-03 Pharmacia & Upjohn Company Oxazolidinone antibacterial agents having a thiocarbonyl functionality
AU9001598A (en) * 1997-09-11 1999-03-29 Hokuriku Seiyaku Co. Ltd Thiourea derivatives
EP1028940B1 (fr) * 1997-11-07 2007-04-18 Pharmacia & Upjohn Company LLC Procede de production d'oxazolidinones
DE19802239A1 (de) * 1998-01-22 1999-07-29 Bayer Ag Neue mit Bicyclen substituierte Oxazolidinone
CA2318969A1 (fr) * 1998-01-23 1999-07-29 Mikhail F. Gordeev Banques combinatoires d'oxazolidinones, compositions a base de tels composes et procedes de preparation
HUP0103082A3 (en) * 1998-06-05 2002-12-28 Astrazeneca Ab Oxazolidinone derivatives, process for their preparation and pharmaceutical compositions containing them
GB9821938D0 (en) * 1998-10-09 1998-12-02 Zeneca Ltd Chemical compounds
JP2000204084A (ja) * 1998-11-11 2000-07-25 Hokuriku Seiyaku Co Ltd チオカルバミド酸誘導体
AU1045300A (en) * 1998-11-17 2000-06-05 Bayer Aktiengesellschaft Novel heterocyclyl-substituted oxazolidone derivatives
AU1379900A (en) * 1998-11-17 2000-06-05 Bayer Aktiengesellschaft Novel substituted phenyloxazolidone derivatives
US6403804B1 (en) 1998-12-07 2002-06-11 Takasago International Corporation Process for preparing optically active oxazolidinone derivative
CN1142162C (zh) 1999-05-27 2004-03-17 法玛西雅厄普约翰美国公司 作为抗菌剂的新的双环噁唑烷酮
MXPA02000985A (es) * 1999-07-28 2002-07-30 Upjohn Co Oxazolidinonas y su uso como antiinfecciosos.
US6608081B2 (en) * 1999-08-12 2003-08-19 Ortho-Mcneil Pharmaceutical, Inc. Bicyclic heterocyclic substituted phenyl oxazolidinone antibacterials, and related compositions and methods
US6413981B1 (en) 1999-08-12 2002-07-02 Ortho-Mcneil Pharamceutical, Inc. Bicyclic heterocyclic substituted phenyl oxazolidinone antibacterials, and related compositions and methods
US6297242B1 (en) 1999-08-12 2001-10-02 Ortho-Mcneil Pharmaceutical, Inc. N-substituted amidine and guanidine oxazolidinone antibacterials and methods of use thereof
GB9928568D0 (en) 1999-12-03 2000-02-02 Zeneca Ltd Chemical compounds
US6518285B2 (en) 1999-12-21 2003-02-11 Ortho Mcneil Pharmaceutical, Inc. Piperidinyloxy and pyrrolidinyloxy oxazolidinone antibacterials
DK1111583T3 (da) 1999-12-23 2003-09-22 Hans-Peter Wilfer Kasse til musikinstrumenter, især guitarer
DE19962924A1 (de) 1999-12-24 2001-07-05 Bayer Ag Substituierte Oxazolidinone und ihre Verwendung
KR100355345B1 (ko) * 2000-01-21 2002-10-12 한국과학기술연구원 티오펜환을 함유한 신규한 옥사졸리디논 유도체, 그의 제조방법 및 조성물
MY127336A (en) * 2000-03-22 2006-11-30 Upjohn Co Container for linezolid iv solution
US6514529B2 (en) 2000-03-22 2003-02-04 Pharmacia & Upjohn Company Oxazolidinone tablet formulation
PE20011124A1 (es) 2000-03-31 2001-10-28 Upjohn Co Nuevos agentes antibacterianos de benzosultam oxazolidinona
GB0009803D0 (en) * 2000-04-25 2000-06-07 Astrazeneca Ab Chemical compounds
AU2001272961A1 (en) 2000-06-30 2002-01-14 Pharmacia & Upjohn Company Compositions for treating bacterial infections containing oxazolidinone compound, sulbactam and an ampicillin
PE20030044A1 (es) * 2000-11-17 2003-02-09 Upjohn Co Isoxazolinonas biciclicas de formula i
AU2002256995A1 (en) * 2001-02-07 2002-08-28 Ortho-Mcneil Pharmaceutical, Inc. Pyridoarylphenyl oxazolidinone antibacterials, and related compositions and methods
DE10129725A1 (de) * 2001-06-20 2003-01-02 Bayer Ag Kombinationstherapie substituierter Oxazolidinone
TW200302095A (en) * 2002-01-25 2003-08-01 Upjohn Co Oxazolidinone cotherapy
US7141588B2 (en) * 2002-02-25 2006-11-28 Pfizer, Inc. N-aryl-2-oxazolidinone-5-carboxamides and their derivatives
AR038536A1 (es) * 2002-02-25 2005-01-19 Upjohn Co N-aril-2-oxazolidinona-5- carboxamidas y sus derivados
WO2003084534A1 (fr) * 2002-03-29 2003-10-16 Pharmacia & Upjohn Company Llc Administration orale, parenterale ou intraveineuse d'oxazolidinones utilisees dans le traitement des infections du pied causees par le diabete
DE60304360T2 (de) * 2002-08-12 2006-11-16 Pharmacia & Upjohn Co. Llc, Kalamazoo N-aryl-2-oxazolidinone und deren derivate
WO2004026848A1 (fr) * 2002-09-20 2004-04-01 Lupin Limited Derives d'oxazolidinone, leur procede de preparation et leur utilisation comme agents antimycobacterients
TW200420573A (en) * 2002-09-26 2004-10-16 Rib X Pharmaceuticals Inc Bifunctional heterocyclic compounds and methods of making and using same
ES2271660T3 (es) * 2002-11-21 2007-04-16 PHARMACIA & UPJOHN COMPANY LLC Derivados de n-(4-piperazin-1-il)-fenil-2-oxazolidinona-5-carboxamida y compuestos relacionados como agentes antibacterianos.
DE10300111A1 (de) * 2003-01-07 2004-07-15 Bayer Healthcare Ag Verfahren zur Herstellung von 5-Chlor-N-({(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)-phenyl]-1,3-oxazolidin-5-yl}-methyl)-2-thiophencarboxamid
BRPI0407304A (pt) * 2003-02-07 2006-01-10 Warner Lambert Co Agentes antibacterianos
CA2515311A1 (fr) * 2003-02-07 2004-08-19 Warner-Lambert Company Llc Agents antibacteriens
US7012088B2 (en) * 2003-02-24 2006-03-14 Pharmacia & Upjohn Company Indolone oxazolidinones and derivatives thereof
US20040204463A1 (en) * 2003-04-01 2004-10-14 Harris Christina Renee N-aryl-2-oxazolidinone-5-carboxamides and their derivatives
BRPI0413838A (pt) * 2003-08-25 2006-10-24 Warner Lambert Co compostos de ariloxazolidinona antimicrobianos
US7304050B2 (en) * 2003-09-16 2007-12-04 Pfizer Inc. Antibacterial agents
DE10355461A1 (de) 2003-11-27 2005-06-23 Bayer Healthcare Ag Verfahren zur Herstellung einer festen, oral applizierbaren pharmazeutischen Zusammensetzung
WO2005082897A1 (fr) * 2004-01-28 2005-09-09 Pharmacia & Upjohn Company Llc Agents antibacteriens oxazolidinone
WO2005082900A2 (fr) * 2004-01-28 2005-09-09 Pharmacia & Upjohn Company Llc Amidoxines d'oxazolidinone utilisees en tant qu'agents antibacteriens
EP1723159B1 (fr) 2004-02-27 2019-06-12 Melinta Therapeutics, Inc. Composes macrocycliques et leurs procedes de fabrication et d'utilisation
DE102004062475A1 (de) * 2004-12-24 2006-07-06 Bayer Healthcare Ag Feste, oral applizierbare pharmazeutische Darreichungsformen mit modifizierter Freisetzung
EP1685841A1 (fr) 2005-01-31 2006-08-02 Bayer Health Care Aktiengesellschaft Prevention et traitement de troubles thromboemboliques
AU2006231919A1 (en) 2005-04-06 2006-10-12 Pharmacia & Upjohn Company Llc 7-fluoro-1,3-dihydro-indol-2-one oxazolidinones as antibacterial agents
EP1934237A2 (fr) 2005-08-24 2008-06-25 Rib-X Pharmaceuticals, Inc. Triazoles et procedes de production et d'utilisation de ces composes
EP1928893A2 (fr) 2005-08-24 2008-06-11 Rib-X Pharmaceuticals, Inc. Composes de triazole et preparation et utilisation de ces composes
DE102005045518A1 (de) 2005-09-23 2007-03-29 Bayer Healthcare Ag 2-Aminoethoxyessigsäure-Derivate und ihre Verwendung
DE102005047558A1 (de) * 2005-10-04 2008-02-07 Bayer Healthcare Ag Kombinationstherapie substituierter Oxazolidinone zur Prophylaxe und Behandlung von cerebralen Durchblutungsstörungen
EP1934208B1 (fr) 2005-10-04 2011-03-23 Bayer Schering Pharma Aktiengesellschaft Nouvelle forme polymorphe de 5-chloro-n-({(5s)-2-oxo-3-[4-(3-oxo-4-morpholinyl)-phenyl]-1,3-oxazolidin-5-yl}-methyl)-2-thiophenecarboxamide
DE102005047561A1 (de) 2005-10-04 2007-04-05 Bayer Healthcare Ag Feste, oral applizierbare pharmazeutische Darreichungsformen mit schneller Wirkstofffreisetzung
WO2008021309A1 (fr) * 2006-08-15 2008-02-21 Wyeth Dérivés d'imidazolidin-2-one utiles en tant que modulateurs pr
US7649007B2 (en) * 2006-08-15 2010-01-19 Wyeth Llc Oxazolidine derivatives as PR modulators
TW200815428A (en) 2006-08-15 2008-04-01 Wyeth Corp Oxazolidone derivatives as PR modulators
US7538107B2 (en) 2006-08-15 2009-05-26 Wyeth Oxazinan-2-one derivatives useful as PR modulators
DE102006051625A1 (de) * 2006-11-02 2008-05-08 Bayer Materialscience Ag Kombinationstherapie substituierter Oxazolidinone
WO2008143649A2 (fr) * 2006-12-04 2008-11-27 Dr. Reddy's Laboratories Limited Nouveaux composés oxazolidinones comme agents anti-infectieux
PL2254887T3 (pl) 2008-02-22 2013-05-31 Actelion Pharmaceuticals Ltd Pochodne oksazolidynonu
WO2018170664A1 (fr) * 2017-03-20 2018-09-27 Merck Sharp & Dohme Corp. Composés d'oxazolidinone et leurs procédés d'utilisation en tant qu'agents antibactériens

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4705799A (en) 1983-06-07 1987-11-10 E. I. Du Pont De Nemours And Company Aminomethyl oxooxazolidinyl benzenes useful as antibacterial agents
US4965268A (en) * 1987-10-09 1990-10-23 E. I. Du Pont De Nemours And Company Aminomethyl oxooxazolidinyl cycloalkylbenzene derivatives useful as antibacterial agents
US5032605A (en) * 1987-10-09 1991-07-16 Du Pont Merck Pharmaceutical Company Aminomethyl oxooxazolidinyl oxa or thia cycloalkylbenzene derivatives useful as antibacterial agents
US4801600A (en) * 1987-10-09 1989-01-31 E. I. Du Pont De Nemours And Company Aminomethyl oxooxazolidinyl cycloalkylbenzene derivatives useful as antibacterial agents
US4942183A (en) * 1987-10-16 1990-07-17 E. I. Du Pont De Nemours And Company Aminomethyl oxooxazolidinyl aroylbenzene derivatives useful as antibacterial agents
CA1320730C (fr) 1987-10-16 1993-07-27 The Du Pont Merck Pharmaceutical Company Derives d'aminomethyloxooxazolidinylaroylbenzene, agents antibacteriens
US5254577A (en) 1988-07-29 1993-10-19 The Du Pont Merck Pharmaceutical Company Aminomethyloxooxazolidinyl arylbenzene derivatives useful as antibacterial agents
US4948801A (en) * 1988-07-29 1990-08-14 E. I. Du Pont De Nemours And Company Aminomethyloxooxazolidinyl arylbenzene derivatives useful as antibacterial agents
US5164510A (en) * 1988-09-15 1992-11-17 The Upjohn Company 5'Indolinyl-5β-amidomethyloxazolidin-2-ones
DE68929303T2 (de) 1988-09-15 2002-05-02 Upjohn Co 3-(Stickstoff substituierte)phenyl-5-beta-amidomethyloxazoliden-2-one
JP2669579B2 (ja) * 1991-10-23 1997-10-29 エーザイ株式会社 オキサゾリドン誘導体
DE4303303C1 (de) 1993-02-05 1994-02-17 Freudenberg Carl Fa Antriebsstrang eines Kraftfahrzeugs
DE4332384A1 (de) 1993-09-23 1995-03-30 Merck Patent Gmbh Adhäsionsrezeptor-Antagonisten III
TW286317B (fr) 1993-12-13 1996-09-21 Hoffmann La Roche
DE4425613A1 (de) 1994-07-20 1996-01-25 Bayer Ag 5-gliedrige Heteroaryl-oxazolidinone
DE4425612A1 (de) 1994-07-20 1996-04-04 Bayer Ag 6-gliedrige stickstoffhaltige Heteroaryl-oxazolidinone
DE4425609A1 (de) 1994-07-20 1996-01-25 Bayer Ag Benzofuranyl- und Benzothienyloxazolidinone
DE19514313A1 (de) * 1994-08-03 1996-02-08 Bayer Ag Benzoxazolyl- und Benzothiazolyloxazolidinone
HRP960159A2 (en) 1995-04-21 1997-08-31 Bayer Ag Benzocyclopentane oxazolidinones containing heteroatoms

Also Published As

Publication number Publication date
AR005703A1 (es) 1999-07-14
CO4560411A1 (es) 1998-02-10
EP0789025A1 (fr) 1997-08-13
CZ34097A3 (en) 1997-08-13
DK0789025T3 (da) 2001-06-18
DE19604223A1 (de) 1997-08-07
HU9700358D0 (en) 1997-03-28
GR3036015T3 (en) 2001-09-28
ZA97927B (en) 1997-08-19
NO970511D0 (no) 1997-02-05
AU1251697A (en) 1997-08-14
TR199700092A2 (tr) 1997-08-21
HUP9700358A3 (en) 1999-08-30
YU4397A (sh) 1999-09-27
EE9700043A (et) 1997-08-15
SI0789025T1 (en) 2001-08-31
JPH09316073A (ja) 1997-12-09
SK15897A3 (en) 1997-10-08
DE59703261D1 (de) 2001-05-10
US5792765A (en) 1998-08-11
EP0789025B1 (fr) 2001-04-04
HRP970048A2 (en) 1998-04-30
IL120125A0 (en) 1997-06-10
ID15881A (id) 1997-08-14
KR970061888A (ko) 1997-09-12
SG50791A1 (en) 1998-07-20
PL318277A1 (en) 1997-08-18
HUP9700358A2 (hu) 1998-07-28
ES2157027T3 (es) 2001-08-01
MX9700886A (es) 1998-04-30
NZ314179A (en) 1998-12-23
CA2196862A1 (fr) 1997-08-07
SV1997000009A (es) 1997-10-23
TW350845B (en) 1999-01-21
BR9700885A (pt) 1998-10-27
BG101193A (en) 1999-02-26
PT789025E (pt) 2001-07-31
NO970511L (no) 1997-08-07
CN1160051A (zh) 1997-09-24
ATE200285T1 (de) 2001-04-15

Similar Documents

Publication Publication Date Title
TNSN97032A1 (fr) Nouvelles oxazolidinones substituees, procedes pour les preparer, et leur utilisation en tant que medicaments.
NO905608D0 (no) Fremgangsmaate for fremstilling av a-nor-steroid-3-karboksylsyrederivater.
AU603525B2 (en) Tetrazole intermediates to antihypertensive compounds
FR2377376A1 (fr) Derives d'hexahydroterphenyle et leur application en tant que cristaux liquides
TR200101961T2 (tr) 1,2-halkalı kinolin türevleri
ES2081000T3 (es) Derivados de hidantoina.
ATE141278T1 (de) Diphosphonsaurederivate als zwischenprodukte zur herstellung von diphosphinliganden
TNSN87012A1 (fr) Nouveaux derives de dihydrobenzofuranne - et de chromane - carboxamides, leurs procedes de preparation et leur utilisation comme neuroleptiques
TR28332A (tr) Arilasetik asit türevleri.
CA2107485A1 (fr) Nouveaux derives d'ellipticine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
SE8600658D0 (sv) Novel composition of matter
DK0865271T3 (da) Stabiliserede solbeskyttelsespræparater
TNSN97033A1 (fr) Nouvelles heteroaryl-oxazolidinones, procede pour les preparer, et leur utilisation en tant que medicaments.
DK167384D0 (da) Penemer,farmaceutiske praeparater indeholdende disse,samt fremgangsmaader til fremstilling deraf
FR2453169A1 (fr) Composes de pyranone substitues en position 6 et leur utilisation comme produits pharmaceutiques
FR2446279A1 (fr) Cis- et trans-3-aryloxy-4-hydroxypyrrolidines et leurs derives, utiles notamment en medecine veterinaire comme antidepresseurs
ATE69448T1 (de) Chinolincarbonsaeure-derivate, diese enthaltende zusammensetzung, verfahren zu ihrer herstellung und ihre verwendung zur herstellung von medikamenten.
FR2442236A1 (fr)
ATE16795T1 (de) Chloressigsaeurecyclohexylamide, ihre herstellung, ihre verwendung zur bekaempfung von unkraeutern und mittel dafuer.
DE3851979D1 (de) Substituierte Vinylcephalosporine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel.
ATE100102T1 (de) Substituierte derivate von 20,21dinoreburnamenin, verfahren zur herstellung und so hergestellte zwischenprodukte, ihre verwendung als arzneimittel und diese enthaltende pharmazeutische zusammenstellungen.
FR2375188A1 (fr) Pour : nitro-amines utilisables comme composantes de diazotation
FR2788769B1 (fr) Nouveaux coupleurs cationiques, leur utilisation pour la teinture d'oxydation, compositions pour la teinture les comprenant, et procedes de teinture
NO842345L (no) Heksahydropyrrolo(2,1-a)isoquinolin-derivater.
DK600585D0 (da) 2,3-diamino-2,3-didesoxyhexosederivater, fremgangsmaade til fremstilling deraf samt anvendelse deraf